Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Biomedica Regulatory News (OXB)

Share Price Information for Oxford Biomedica (OXB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 300.00
Bid: 300.50
Ask: 310.50
Change: 0.00 (0.00%)
Spread: 10.00 (3.328%)
Open: 300.00
High: 300.00
Low: 300.00
Prev. Close: 300.00
OXB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

17 Jun 2010 11:38

RNS Number : 7921N
Oxford Biomedica PLC
17 June 2010
 



For immediate release

17 June 2010

 

Oxford BioMedica Plc

Notification of Major Interest in Shares

 

TR-1: Notifications of Major Interests in Shares

 

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:

Oxford BioMedica Plc

 

2. Reason for notification (yes/no)

 

An acquisition or disposal of voting rights

Yes

 

An acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

 

An event changing the breakdown of voting rights

 

Other (please specify):

 

3. Full name of person(s) subject to notification obligation:

 

Legal & General Group Plc (L&G)

 

4. Full name of shareholder(s) (if different from 3):

Legal & General Assurance (Pensions Management) Limited (PMC)

 

5. Date of transaction (and date on which the threshold is crossed or reached if different):

 

15 June 2010

 

6. Date on which issuer notified:

 

16 June 2010

 

7. Threshold(s) that is/are crossed or reached:

 

From 4% to 3%

 

8: Notified Details

A: Voting rights attached to shares

 

Class/type of shares

If possible use ISIN code GB0006648157

Situation previous to the triggering transaction

Resulting situation after the triggering transaction

 

 

Number of shares 22,476,084

 

Number of voting rights 22,476,084

Number of shares 21,605,215

Number of voting rights

Percentage of voting rights

Direct 21,605,215

 Indirect

 

 Direct 3.98%

 Indirect

B: Financial Instruments

 

Resulting situation after the triggering transaction

 

Type of financial instrument

Expiration date

Exercise/ conversion period/date

No. of voting rights that may be acquired (if the instrument exercised/converted)

Percentage of voting rights

 

 

Total (A+B)

 

Number of voting rights

Percentage of voting rights

21,605,215

3.98%

 

9. Chain of controlled undertakings through which the voting rights and /or the financial instruments are effectively held, if applicable:

 

Legal & General Group Plc (Direct and Indirect) (Group)

 

Legal & General Investment Management (Holdings) Limited (LGIMH) (Direct and Indirect)

 

Legal & General Investment Management Limited (Indirect) (LGIM)

 

Legal & General Group Plc (Direct) (L&G) ( 21,605,215 - 3.97%= LGAS, LGPL & PMC)

Legal & General Investment Management (Holdings) Limited (Direct) (LGIMHD) (19,907,441 - 3.66%= PMC)

Legal & General Insurance Holdings Limited (Direct) (LGIH)

Legal & General Assurance (Pensions Management) Limited (PMC) ( 19,907,441 - 3.66%= PMC)

Legal & General Assurance Society Limited (LGAS & LGPL)

Legal & General Pensions Limited (Direct) (LGPL)

 

Proxy Voting:

10. Name of proxy holder:

 

11. Number of voting rights proxy holder will cease to hold:

 

12. Date on which proxy holder will cease to hold voting rights:

 

 

13. Additional information:

 

14 Contact name:

 

Andrew Wood

15. Contact telephone number:

 

01865 783000

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLUBORRRNANAAR
Date   Source Headline
20th May 20202:34 pmRNSHolding(s) in Company
13th May 20206:02 pmRNSHolding(s) in Company
13th May 20207:00 amRNSOXB receives approval for first two Oxbox suites
11th May 20204:25 pmRNSPDMR Dealings / Market Share sale
6th May 202012:36 pmRNSDirectors Dealings / Market Share Purchases
6th May 20207:00 amRNSPreliminary Results
1st May 20209:05 amRNSTotal Voting Rights
28th Apr 20201:04 pmRNSCompliance with LR 9.2.6ER(1)
24th Apr 202011:48 amRNSDirector/PDMR Shareholding
23rd Apr 20208:38 amRNSHolding(s) in Company
22nd Apr 202012:03 pmRNSKymriah receives FDA RMAT designation in FL
20th Apr 20204:49 pmRNSHolding(s) in Company
16th Apr 20203:17 pmRNSNotice of Results Update
8th Apr 20207:00 amRNSOxford Biomedica joins COVID-19 vaccine Consortium
1st Apr 20209:31 amRNSTotal Voting Rights
25th Mar 20201:06 pmRNSDirector Dealings / Market Share Purchase
20th Mar 20209:56 amRNSDirector/PDMR Shareholding
18th Mar 20207:00 amRNSOxford Biomedica Business Update
18th Mar 20207:00 amRNSLicense & Supply Agreement with Juno Therapeutics
2nd Mar 20209:22 amRNSTotal Voting Rights
26th Feb 20205:55 pmRNSDirector Dealings / Market Share Purchase
3rd Feb 20205:04 pmRNSClass 2 Transaction Announcement
3rd Feb 202011:56 amRNSTotal Voting Rights
3rd Feb 202011:55 amRNSDirector Dealings / Market Share Purchase
22nd Jan 202012:11 pmRNSBlock listing Application
7th Jan 202010:17 amRNSBlock Listing Return
2nd Jan 202011:41 amRNSTotal Voting Rights
19th Dec 20193:27 pmRNSDirector Dealings / Market Share Purchase
19th Dec 20197:00 amRNSExtension of Commercial Supply Agreement
2nd Dec 20199:31 amRNSTotal Voting Rights
27th Nov 201910:05 amRNSDirector Dealings / Market Share Purchase
13th Nov 20194:41 pmRNSHolding(s) in Company
1st Nov 20199:25 amRNSTotal Voting Rights
28th Oct 201912:30 pmRNSDirector Dealings / Market Share Purchase
23rd Oct 20197:00 amRNSHolding(s) in Company
23rd Oct 20197:00 amRNSHolding(s) in Company
16th Oct 20197:30 amEQSHardman & Co Research: Oxford BioMedica (OXB): Demanding second half
1st Oct 201910:18 amRNSTotal Voting Rights
25th Sep 201911:41 amRNSDirector Dealings / Market Share Purchase
16th Sep 201911:18 amRNSDirector/PDMR Shareholding
16th Sep 20199:15 amRNSDirectors Dealings / Market Share Purchases
13th Sep 20192:57 pmRNSLong Term Incentive Plan Option Grant
13th Sep 20191:13 pmRNSDirectors Dealings / Market Share Purchases
13th Sep 201910:53 amRNSDirector Dealings / Market Share Purchase
4th Sep 20197:00 amRNSOxford Biomedica Interim Results
2nd Sep 20199:31 amRNSTotal Voting Rights
23rd Aug 201911:06 amRNSDirector Dealings / Market Share Purchase
9th Aug 201912:00 pmRNSNotice of Interim Results
1st Aug 20199:18 amRNSTotal Voting Rights
25th Jul 20192:17 pmRNSDirector Dealings / Market Share Purchase

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.